Industrie BORLA S.p.A.

Why Borla

For Borla, a multinational company that works at the highest levels of technology and productivity, organization is key. Synergy, integration, autonomy, competence, and management are combined to deliver a greater benefit. A high level of efficiency is achieved every day through the precise coordination of processes, and the high quality deliverables reflect the way every phase is managed.

• In-house manufacturing and oversight of each product delivers higher efficiency and enhanced product range quality.
• Each new project is closely monitored with Borla’s proprietary, step-by-step monitored program management processes.
• From start to finish, precision and accuracy are maximised in product design, concept, development and distribution.
• Production expertise is enhanced through the collaborative processes in design, mold construction, molding, assembly and logistics.

Independence, production capacity, precision at every stage, but, above all, organization.

Advantages

• Broad experience in plastic and rubber components for medical applications since 1965.
• Continual investment in technology and production facilities.
• Eight automated factories.
• In-house manufacturing.
• The latest production technology.
• Sales presence in more than 65 countries worldwide.
• Research and development carried out to the highest standards.
• Design and prototyping using the most advanced software.
• 3 clean rooms for molding.
• 4 clean rooms for assembly.
• Ten product segments with over 2,000 types of diversified components.
• Packaging, warehousing and logistics that shorten the time-to-market.

Mission
The mission that guides our company is to manufacture plastic and rubber components for medical applications. The aim is to combine cutting-edge technology, automation and engineering in products that match the highest quality standards. Borla products are products of excellence: infusion and transfusion set components, blood line components, connectors and caps, clamps and roller clamps, injection sites, needlefree systems components, check valves, burette components, i.v. filters, stopcocks and syringes.

It’s an integrated and complete process, from engineering to prototyping, from molding to assembly, right up to logistics.

Vision
Quality, cutting-edge technology, organization. Entering global markets with entrepreneurial business spirit. Increasing production capacity through innovation, research, and constant development. Acquiring new sales partners, conquering new market share and being the leader in pharmaceutical components, particularly in terms of the quality of our every project, recognized at a global level by a growing market.

Corporate responsibility
The conscientious approach of a large multinational company is demonstrated by its level of corporate responsibility; it must accept that it is part of a well-defined social context. Borla is a company that is inspired by ethical values: every single person’s contribution and all ideas help make a company great. There is room for cooperation and synergy, factors that raise the business to new heights.

We offer our customers the best. In an environment of positive feedback, we have earned enormous trust and loyalty in our long history, a trust and loyalty that we want to respect and live up to, always.

Furthermore, Borla is sensitive to environmental issues when it comes to manufacturing: our production processes meet sustainable requirements with the highest level of research and development procedures.

Borla was founded in 1965: from the very beginning, our core business was to manufacture plastic and rubber components for medical applications.

The company reacted strategically to the expansion of a market brimming with opportunities. In 1972 it acquired the Borla Gomma di Varese production facility (Italy), which specializes in molding components in natural latex and synthetic rubber.

Borla then established its brand on a global level: in 1991 it acquired the Listal industrial facility in Ireland, which specializes in insert molding components with membrane or filter media. In 1998 sales horizons expanded beyond the ocean, with offices in California and a distribution center in Memphis, USA. In 2007 trade offices were also opened in Brazil and Russia.

In 2008 Borla also took over Comef in Modena (Italy), which specializes in dialysis kit components, accessories for blood infusion and transfusion and connectors for extracorporeal circulation. In 2010 it acquired Yukon Medical, in North Carolina (USA), which specializes in the development of innovative pharmaceutical preparation and delivery devices.

Today Borla has four production facilities in its headquarters in Turin with seven fully automated clean rooms for molding and assembly.

It’s a story of past successes, present leadership, and a future at the cutting edge: we invest in technology, we deliver innovation.